Retrospective Study
Copyright ©The Author(s) 2021.
World J Diabetes. Feb 15, 2021; 12(2): 158-169
Published online Feb 15, 2021. doi: 10.4239/wjd.v12.i2.158
Table 2 Differences in the concentration of various tumor biomarkers between patients with and without intraocular metastasis
Clinical features
IOM group
NIOM group
t
P value
AFP1030.37 ± 342.38526.37 ± 587.16-5.17< 0.001
CEA6.54 ± 14.75389.37 ± 10012.620.1380.89
CA125419.78 ± 356.43148.03 ± 305.88-3.1650.002
CA199200.35 ± 329.82314.22 ± 4482.590.0920.927
CA15319.81 ± 15.0620.32 ± 23.280.0780.938
CA7246.68 ± 8.446.91 ± 12.320.0660.947
FER198.23 ± 52.50259.43 ± 224.570.9810.327
ALP192.54 ± 94.07174.15 ± 171.39-0.3860.7
TC4.75 ± 1.205.14 ± 8.620.1610.872
TG1.44 ± 0.811.37 ± 1.03-0.2570.797
HDL1.30 ± 0.641.50 ± 1.170.6020.548
LDL2.52 ± 1.162.58 ± 1.430.1440.885
ApoA11.65 ± 0.451.57 ± 0.87-0.3310.741
ApoB0.77 ± 0.321.10 ± 0.821.4260.154
Lp(a)181.92 ± 219.72221.66 ± 240.540.5910.555
Ca14.56 ± 44.902.14 ± 0.27-0.9970.338
Hb114.69 ± 43.54117.19 ± 22.310.2070.84